Loading clinical trials...
Loading clinical trials...
The main purpose of this study is to understand the pharmacokinetics of EP-104IAR and to determine whether it is safe to use in patients with osteoarthritis (OA) of the knee. The study will also provi...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Eupraxia Pharmaceuticals Inc.
Collaborators
NCT05986292 · Osteoarthritis, Knee, Diabetic Neuropathic Pain, and more
NCT06234631 · Knee Replacement Surgery, Osteoarthritis, Knee
NCT07364578 · Osteoarthritis, Knee
NCT06488144 · Osteoarthritis, Knee
NCT07058623 · Arthroplasty, Replacement, Knee, Osteoarthritis, Knee
Rebalance MD
Victoria, British Columbia
Centre for Studies in Family Medicine
London, Ontario
Fowler Kennedy Sports Medicine Clinic
London, Ontario
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions